Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $302.93 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $60.15 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $30.50 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $27.13 | 2 | $0 (2021) |
| Amgen Inc. | $22.79 | 1 | $0 (2022) |
| Abbott Laboratories | $19.86 | 1 | $0 (2022) |
| BioMarin Pharmaceutical Inc. | $19.20 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.97 | 1 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $17.85 | 1 | $0 (2021) |
| Alnylam Pharmaceuticals Inc. | $17.70 | 1 | $0 (2022) |
| SANOFI PASTEUR INC. | $17.04 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.11 | 3 | BioMarin Pharmaceutical Inc. ($19.20) |
| 2022 | $112.15 | 5 | E.R. Squibb & Sons, L.L.C. ($33.71) |
| 2021 | $140.67 | 10 | Janssen Pharmaceuticals, Inc ($27.13) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | SANOFI PASTEUR INC. | MENQUADFI (Biological), VAXELIS, BEYFORTUS | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Vaccines | ||||||
| 11/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $13.87 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/02/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Achondroplasia | ||||||
| 06/15/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $33.71 | General |
| Category: Cardiovascular | ||||||
| 05/10/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Heart Failure | ||||||
| 02/14/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Genetic Disease | ||||||
| 01/19/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Cardiology | ||||||
| 01/11/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: DIABETES | ||||||
| 11/30/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiology | ||||||
| 11/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Cardiovascular | ||||||
| 06/17/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Cardiovascular | ||||||
| 03/30/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/10/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Cardiovascular | ||||||
| 02/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 12 | $3,936 | $1,252 |
| 2022 | 6 | 512 | 541 | $66,200 | $29,957 |
| 2021 | 6 | 699 | 731 | $89,103 | $26,997 |
| 2020 | 6 | 600 | 642 | $96,232 | $21,902 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,936 | $1,252 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 351 | 370 | $41,118 | $20,542 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 43 | 46 | $5,092 | $2,775 | 54.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $9,380 | $2,419 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 20 | $2,740 | $1,692 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 51 | $4,180 | $1,561 | 37.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 20 | $3,380 | $904.06 | 26.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 14 | 14 | $310.00 | $63.75 | 20.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 368 | 396 | $52,761 | $15,624 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 83 | $11,720 | $5,108 | 43.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 162 | 163 | $13,609 | $3,206 | 23.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 28 | 29 | $3,845 | $1,180 | 30.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $3,274 | $1,034 | 31.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 17 | $2,261 | $423.40 | 18.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 17 | 17 | $1,343 | $350.25 | 26.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 14 | 14 | $290.00 | $70.46 | 24.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 373 | 405 | $56,671 | $11,820 | 20.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 94 | $19,285 | $4,735 | 24.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 89 | 89 | $11,837 | $2,878 | 24.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $4,895 | $1,448 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 19 | $3,040 | $897.94 | 29.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 24 | 24 | $504.00 | $122.87 | 24.4% |
About Michelle Hardie
Michelle Hardie is a Physician Assistant healthcare provider based in Sheldon, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366576563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Hardie has received a total of $302.93 in payments from pharmaceutical and medical device companies, with $50.11 received in 2024. These payments were reported across 18 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($302.93).
As a Medicare-enrolled provider, Hardie has provided services to 1,823 Medicare beneficiaries, totaling 1,926 services with total Medicare billing of $80,108. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Sheldon, IA
- Active Since 03/16/2007
- Last Updated 09/05/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1366576563
Products in Payments
- ELIQUIS (Drug) $38.43
- CAMZYOS (Drug) $33.71
- VERQUVO (Drug) $30.50
- XARELTO (Drug) $27.13
- Repatha (Biological) $22.79
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $19.86
- VOXZOGO 1.2mg (Drug) $19.20
- JARDIANCE (Drug) $17.97
- OPSUMIT (Drug) $17.85
- ONPATTRO (Drug) $17.70
- MENQUADFI (Biological) $17.04
- NEXLIZET (Drug) $14.40
- JORNAY PM (Drug) $13.87
- Vascepa (Drug) $12.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Sheldon
Katherine Haverly, Pa-C, PA-C
Physician Assistant — Payments: $11.37
Jack Myers, P.a, P.A
Physician Assistant
Rosalyn Mulder, P.a, P.A
Physician Assistant
Sandra Muyskens, Pa-C, PA-C
Physician Assistant
Kendra Bos, Pa-C, PA-C
Physician Assistant
Courtney Stiens
Physician Assistant